ICE Stock Overview
Focuses on creating, developing, and commercializing medical technologies for cardiology and cardio surgery. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Medinice S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł8.60 |
| 52 Week High | zł13.50 |
| 52 Week Low | zł7.00 |
| Beta | 1.12 |
| 11 Month Change | -2.82% |
| 3 Month Change | -22.52% |
| 1 Year Change | -10.04% |
| 33 Year Change | -62.61% |
| 5 Year Change | -4.44% |
| Change since IPO | -20.37% |
Recent News & Updates
Shareholder Returns
| ICE | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -11.8% | -4.8% | -3.6% |
| 1Y | -10.0% | -10.1% | -0.01% |
Return vs Industry: ICE matched the Polish Medical Equipment industry which returned -9.9% over the past year.
Return vs Market: ICE underperformed the Polish Market which returned 1.1% over the past year.
Price Volatility
| ICE volatility | |
|---|---|
| ICE Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in PL Market | 8.6% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: ICE's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: ICE's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 16 | Sanjeev Choudhary | www.medinice.pl |
Medinice S.A. focuses on creating, developing, and commercializing medical technologies for cardiology and cardio surgery. The company provides advisory services in the field of commercialization of research and development products; and undertakes preclinical tests, clinical trials, and obtaining a certificate for sale of medical technology. Medinice S.A. was incorporated in 2012 and is headquartered in Warsaw, Poland.
Medinice S.A. Fundamentals Summary
| ICE fundamental statistics | |
|---|---|
| Market cap | zł55.58m |
| Earnings (TTM) | -zł4.74m |
| Revenue (TTM) | zł221.00k |
251.5x
P/S Ratio-11.7x
P/E RatioIs ICE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICE income statement (TTM) | |
|---|---|
| Revenue | zł221.00k |
| Cost of Revenue | zł140.00k |
| Gross Profit | zł81.00k |
| Other Expenses | zł4.82m |
| Earnings | -zł4.74m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.73 |
| Gross Margin | 36.65% |
| Net Profit Margin | -2,145.25% |
| Debt/Equity Ratio | 0% |
How did ICE perform over the long term?
See historical performance and comparison